Ad
Sunday, 19 March 2017
Newer type 2 diabetes drugs show heart protective quality in study
WASHINGTON (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death and hospitalization for heart failure compared with other medicines for the disease, according to data released on Sunday from a so-called real world study sponsored by AstraZeneca.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment